Skip to main content
Log in

Digital Image Analysis of the Distribution of Proliferating Cell Nuclear Antigen in Hepatitis C Virus-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Viral dynamic studies in chronic hepatitis C virus (HCV) infection indicate a significantly shortened survival of virus-infected cells. Since at the steady state of chronic viral infection, the rate of infected cell elimination equals new cell regeneration, this would imply a high rate of hepatocyte turnover in chronic HCV liver disease. We estimated the fraction of regenerating hepatocytes in liver biopsy sections in chronic HCV liver disease, cirrhosis, and hepatocellular carcinoma (HCC). We used antibodies to proliferating cell nuclear antigen (PCNA) to detect proliferating cell nuclei in liver biopsy specimen from controls and patients with chronic hepatitis, cirrhosis, and HCC. We also used bis-benzimide to label fluorescently all hepatocyte nuclei simultaneously. Using digital image analysis, we calculated the area occupied by PCNA-stained hepatocyte nuclei, as a fraction of the total area occupied by fluorescently labeled hepatocyte nuclei (labeling index; LI). Antibody staining was negligible in the control specimen. The mean ± SE PCNA LI increased from 0.21 ± 0.1 in chronic hepatitis to 0.63 ± 0.15 in HCC. There was no significant difference between chronic hepatitis and cirrhosis. The fraction of cells undergoing regeneration is increased in chronic HCV liver disease, HCV-related cirrhosis, and HCC. Increased hepatocyte turnover could provide the link between chronic HCV liver disease and HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Zeuzem S, Schmidt JM, Lee J-H, Ruster B, Roth WK: Effect of interferon alpha on the dynamics of hepatitis C virus turnover in vivo. Hepatology 23:3663–71, 1996

    Google Scholar 

  2. Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ: Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha. Hepatology 26:226–231, 1997

    Google Scholar 

  3. Fukumoto T, Berg T, Ku Y, et al: Viral dynamics of hepatitis C early after orthopic liver transplantation: Evidence for rapid turnover of serum virions. Hepatology 24:1351–1354, 1996

    Google Scholar 

  4. Neumann AU, Lam NP, Dahari H, et al: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy. Science 282:103–107, 1998

    Google Scholar 

  5. Zeuzem S, Schmidt JM, Lee J-H, von Wagner M, Teuber G, Roth WK: Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alpha on viral turnover. Hepatology 28:245–252, 1998

    Google Scholar 

  6. Lake-Bakaar G, Ruffini L, Kuzmic P: HCV viral dynamics during therapy with interferon-a-2b plus or minus ribavirin: Correlation with ALT suggests ribavirin may prevent de novo re-infection? (submitted for DDW presentation, San Diego, 2000) Gastroenterology 118(4):A1016; 2000

    Google Scholar 

  7. Bekkering FC, Brouwer JT, Leroux-Roels G, Van Vlierberghe H, Elewaut A, Schalm SW: Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy. J Hepatol 28(6):960–964, 1998

    Google Scholar 

  8. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA: Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287:1253–1258, 2000

    Google Scholar 

  9. Colombo M: Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma. J Hepatol 31(Suppl 1):25–30, 1999

    Google Scholar 

  10. Kitamura T, Watanabe S, Sato N: Liver regeneration, liver cancers and cyclins. J Gastroenterol Hepatol 13(Suppl):S96–S99, 1990

    Google Scholar 

  11. Lake-Bakaar G, Sorbi D, Mazzoccoli V: Nitric oxide and chronic HCV and HIV infections. Dig Dis Sci 46(5):1072–1076, 2001

    Google Scholar 

  12. Delhaye M, Louis H, Degraff C, et al: Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis. Hepatology 23:1003–1011, 1996

    Google Scholar 

  13. Negro F, Papotti M, Taraglio S, et al: Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non-neoplastic liver tissues. J Viral Hepatol 4:93–98, 1997

    Google Scholar 

  14. Farinati F, Cardin R, D'Errico A, et al: Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: The role of etiology, disease activity, iron, and lipid peroxidation. Hepatology 23:1468–1475, 1996

    Google Scholar 

  15. Nakamura T, Hayama M, Sakai T, Hotchi M, Tanaka E: Proliferative activity of hepatocytes in chronic viral hepatitis is revealed by immunohistochemistry for proliferating cell nuclear antigen. Hum Pathol 24:750–753, 1993

    Google Scholar 

  16. Urabe Y, Nouso K, Higashi T, et al: Telomere length in human liver diseases. Liver 16(5):293–297, 1996

    Google Scholar 

  17. Kitada T, Seki S, Kawakita N, Kuroki T, Monna T: Telomere shortening in in chronic liver diseases. Biochem Biophys Res Commun 211:33–39, 1995

    Google Scholar 

  18. Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M: Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 112(2):493–500, 1997

    Google Scholar 

  19. Miura M, Horikawa I, Nishimoto A, et al: Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 93(1):56–62, 1997

    Google Scholar 

  20. Edamoto Y, Tani M, Kurata T, Abe K: Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues. Cancer 77:1787–1791, 1996

    Google Scholar 

  21. Lee H-S, Han CJ, Kim CY: Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis Bendemic area. Cancer 72:2564–2567, 1993

    Google Scholar 

  22. Moriya K, Fujie H, Shintani Y, et al: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4(9):1065–1067, 1998

    Google Scholar 

  23. Donato MF, Degott C, Arosio E, et al: Liver cell proliferation in patients with chronic hepatitis C is reduced by interferon therapy. Hepatology 32(4):806A, 2000

    Google Scholar 

  24. Kato Y, Nakata K, Omagari K, et al: Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 74(8):2234–2238, 1994

    Google Scholar 

  25. Toyoda H, Kumada T, Nakano S, et al: The effect of retreatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C. Cancer 88(1):58–65, 2000

    Google Scholar 

  26. Baffis V, Shrier I, Sherker AH, Szilagyi A: Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection. Ann Intern Med 131(9):696–701, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lake-Bakaar, G., Mazzoccoli, V. & Ruffini, L. Digital Image Analysis of the Distribution of Proliferating Cell Nuclear Antigen in Hepatitis C Virus-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma. Dig Dis Sci 47, 1644–1648 (2002). https://doi.org/10.1023/A:1015800126283

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015800126283

Navigation